Ralf Amann

5PUBLICATIONS
17CO-AUTHORS
Animal protection (incl. pests and pathogens)Innate immunityPredictive and prognostic markersGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding <i>ORFV 011</i> and <i>ORFV 059</i> Genes.

|Jan 28, 2026
Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

Alena Reguzova, Melanie Müller, Madeleine Fandrich

|Jul 05, 2025
Commentary on 'Confounding Variable in Recent Clinical Trial on ORFV-Based Therapeutics'.

Matthias Helmold, Ralf Amann

|May 10, 2025
Advancing ORFV-Based Therapeutics to the Clinical Stage.

Matthias Helmold, Ralf Amann

|Nov 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

Meral Esen, Johanna Fischer-Herr, Julian Justin Gabor

Pageof 1

Frequent Collaborators

1 joint publications

Johanna Fischer-Herr

1 joint publications

Sabine Bélard

1 joint publications

Carlos Lamsfus Calle

1 joint publications

Tamirat Gebru Woldearegai